Hyperliquid Strategies files audited Sonnet FY2025 financials after combo

Hyperliquid Strategies Inc

Sonnet's audited financials for FY ended Sep 30, 2025 filed; pro forma data included.
Market value of Sonnet common equity held by non-affiliates: $4.15M as of Mar 31, 2025 ($1.34/share).
Sonnet is a clinical-stage oncology biotech with FHAB platform; lead SON-1010 in solid tumors.
Business combination closed Dec 2, 2025; Hyperliquid now wholly owns Sonnet.
Sonnet has history of operating losses and requires significant additional capital.

item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-055449
form_type: 8-K/A
ticker: PURR
cik: 0002078856
company_name: Hyperliquid Strategies Inc
filed_at: 2026-02-18T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.197459+00:00
generated_at: 2026-05-16T02:12:00.482753+00:00
sec_items: ["9.01"]
event_type: m_and_a
sentiment: neutral
materiality_score: 0.5
confidence: medium
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-055449
json_url: https://secwatch.observer/filing/0001193125-26-055449.json
markdown_url: https://secwatch.observer/filing/0001193125-26-055449.md
text_url: https://secwatch.observer/filing/0001193125-26-055449.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2078856/000119312526055449/0001193125-26-055449-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2078856/000119312526055449/purr-20251202.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-055449

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.